Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Consulting agrmnt
|
|
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| ETF MANAGERS GROUP, LLC reports a 8.8% stake in Corbus Pharmaceuticals Holdings Inc. |
| 06/01/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 04/09/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/17/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/08/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/11/2020 |
SC 13G/A
| ETF MANAGERS GROUP, LLC reports a 9.7% stake in * Corbus Pharmaceuticals Holdings Inc. |
| 11/16/2020 |
SC 13G/A
| ETF MANAGERS GROUP, LLC reports a 8.4% stake in Corbus Pharmaceuticals Holdings Inc. |
| 11/06/2020 |
SC 13G/A
| ETF MANAGERS GROUP, LLC reports a 5.1% stake in Corbus Pharmaceuticals Holdings Inc. |
| 10/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/07/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 04/24/2020 |
SC 13G/A
| ETF MANAGERS GROUP, LLC reports a 5% stake in Corbus Pharmaceuticals Holdings Inc. |
| 03/19/2020 |
SC 13G/A
| ETF MANAGERS GROUP, LLC reports a 5% stake in Corbus Pharmaceuticals Holdings Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 8.4% stake in CORBUS PHARMACEUTICALS HOLDINGS INC |
| 12/02/2019 |
SC 13G/A
| ETF MANAGERS GROUP, LLC reports a 8.4% stake in Corbus Pharmaceuticals Holdings Inc. |
| 06/03/2019 |
SC 13G/A
| ETF MANAGERS GROUP, LLC reports a 10.8% stake in Corbus Pharmaceuticals Holdings Inc. |
| 04/29/2019 |
SC 13G/A
| ETF MANAGERS GROUP, LLC reports a 9.8% stake in Corbus Pharmaceuticals Holdings Inc. |
| 02/19/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Tepper Mark reports a 5.4% stake in CORBUS PHARMACEUTICALS HOLDINGS, INC. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Cormorant Asset Management, LLC reports a 0% stake in Corbus Pharmaceuticals Holdings, Inc. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Tepper Mark reports a 5.4% stake in CORBUS PHARMACEUTICALS HOLDINGS, INC. |
| 03/06/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/02/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/14/2017 |
SC 13G/A
| Corbus Pharmaceuticals Holdings, Inc. reports a 5.2% stake in Corbus Pharmaceuticals Holdings, Inc. |
|
|
|